-
1
-
-
84948970562
-
Ebolavirus Evolution: Past and Present
-
de La Vega, M.-A, Stein, D, Kobinger, G.P. Ebolavirus Evolution: Past and Present. PLoS Pathog. 2015, 11, e1005221.
-
(2015)
Plos Pathog
, vol.11
-
-
De La Vega, M.-A.1
Stein, D.2
Kobinger, G.P.3
-
2
-
-
84924806083
-
-
World Health Organization, (accessed on 15 April 2016)
-
World Health Organization. Ebola Situation Reports. Available online: http://apps.who.int/ebola/ebolasituation- reports (accessed on 15 April 2016).
-
Ebola Situation Reports
-
-
-
3
-
-
84931393635
-
Persistence of Ebola Virus in Ocular Fluid during Convalescence
-
Varkey, J.B, Shantha, J.G, Crozier, I, Kraft, C.S, Lyon, G.M, Mehta, A.K, Kumar, G, Smith, J.R, Kainulainen, M.H, Whitmer, S, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N. Engl. J. Med. 2015, 372, 2423-2427. [CrossRef] [PubMed]
-
(2015)
N. Engl. J. Med
, vol.372
, pp. 2423-2427
-
-
Varkey, J.B.1
Shantha, J.G.2
Crozier, I.3
Kraft, C.S.4
Lyon, G.M.5
Mehta, A.K.6
Kumar, G.7
Smith, J.R.8
Kainulainen, M.H.9
Whitmer, S.10
-
4
-
-
84937726102
-
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study
-
[CrossRef]
-
Clark, D.V, Kibuuka, H, Millard, M, Wakabi, S, Lukwago, L, Taylor, A, Eller, M.A, Eller, L.A, Michael, N.L, Honko, A.N, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study. Lancet Infect. Dis. 2015, 15, 905-912. [CrossRef]
-
(2015)
Lancet Infect. Dis
, vol.15
, pp. 905-912
-
-
Clark, D.V.1
Kibuuka, H.2
Millard, M.3
Wakabi, S.4
Lukwago, L.5
Taylor, A.6
Eller, M.A.7
Eller, L.A.8
Michael, N.L.9
Honko, A.N.10
-
5
-
-
84947457452
-
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report
-
[CrossRef] [PubMed]
-
Deen, G.F, Knust, B, Broutet, N, Sesay, F.R, Formenty, P, Ross, C, Thorson, A.E, Massaquoi, T.A, Marrinan, J.E, Ervin, E, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report. N. Engl. J. Med. 2015. [CrossRef] [PubMed]
-
(2015)
N. Engl. J. Med
-
-
Deen, G.F.1
Knust, B.2
Broutet, N.3
Sesay, F.R.4
Formenty, P.5
Ross, C.6
Thorson, A.E.7
Massaquoi, T.A.8
Marrinan, J.E.9
Ervin, E.10
-
6
-
-
84949460157
-
Molecular Evidence of Sexual Transmission of Ebola Virus
-
Mate, S.E, Kugelman, J.R, Nyenswah, T.G, Ladner, J.T, Wiley, M.R, Cordier-Lassalle, T, Christie, A.; Schroth, G.P, Gross, S.M, Davies-Wayne, G.J, et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N. Engl. J. Med. 2015, 373, 2448-2454. [CrossRef] [PubMed]
-
(2015)
N. Engl. J. Med
, vol.373
, pp. 2448-2454
-
-
Mate, S.E.1
Kugelman, J.R.2
Nyenswah, T.G.3
Ladner, J.T.4
Wiley, M.R.5
Cordier-Lassalle, T.6
Christie, A.7
Schroth, G.P.8
Gross, S.M.9
Davies-Wayne, G.J.10
-
7
-
-
84907263545
-
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
-
Qiu, X, Wong, G, Audet, J, Bello, A, Fernando, L, Alimonti, J.B, Fausther-Bovendo, H, Wei, H, Aviles, J, Hiatt, E, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014, 514, 47-53. [CrossRef] [PubMed]
-
(2014)
Nature
, vol.514
, pp. 47-53
-
-
Qiu, X.1
Wong, G.2
Audet, J.3
Bello, A.4
Fernando, L.5
Alimonti, J.B.6
Fausther-Bovendo, H.7
Wei, H.8
Aviles, J.9
Hiatt, E.10
-
8
-
-
84971302449
-
PREVAIL II: A Randomized Controlled Trial of ZMapp™ in Acute Ebola Virus Infection
-
Boston, MA, USA, 22-25 February
-
Davey, R.T. PREVAIL II: A Randomized Controlled Trial of ZMapp™ in Acute Ebola Virus Infection. In Proceddings of Retroviruses and Opportunistic Infections, Boston, MA, USA, 22-25 February 2016.
-
(2016)
Proceddings of Retroviruses and Opportunistic Infections
-
-
Davey, R.T.1
-
9
-
-
84918795472
-
Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease? Lancet Glob
-
[CrossRef]
-
Almansa, R, Eiros, J.M, Fedson, D, Bermejo-Martin, J.F. Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease? Lancet Glob. Health 2014, 2, 686. [CrossRef]
-
(2014)
Health
, vol.686
, pp. 2
-
-
Almansa, R.1
Eiros, J.M.2
Fedson, D.3
Bermejo-Martin, J.F.4
-
10
-
-
84859462127
-
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
-
Dye, J.M, Herbert, A.S, Kuehne, A.I, Barth, J.F, Muhammad, M.A, Zak, S.E, Ortiz, R.A, Prugar, L.I, Pratt, W.D. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. USA 2012, 109, 5034-5039. [CrossRef] [PubMed]
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 5034-5039
-
-
Dye, J.M.1
Herbert, A.S.2
Kuehne, A.I.3
Barth, J.F.4
Muhammad, M.A.5
Zak, S.E.6
Ortiz, R.A.7
Prugar, L.I.8
Pratt, W.D.9
-
11
-
-
84904819684
-
Ebola drugs still stuck in lab
-
Enserink, M. Ebola drugs still stuck in lab. Science 2014, 345, 364-365. [CrossRef] [PubMed]
-
(2014)
Science
, vol.345
, pp. 364-365
-
-
Enserink, M.1
-
12
-
-
84896129506
-
Successful treatment of advanced Ebola virus infection with T-705 (Favipiravir) in a small animal model
-
Oestereich, L, Lüdtke, A, Wurr, S, Rieger, T, Muñoz-Fontela, C, Günther, S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antivir. Res. 2014, 105, 17-21. [CrossRef] [PubMed]
-
(2014)
Antivir. Res
, vol.105
, pp. 17-21
-
-
Oestereich, L.1
Lüdtke, A.2
Wurr, S.3
Rieger, T.4
Muñoz-Fontela, C.5
Günther, S.6
-
13
-
-
84929505474
-
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
-
Thi, E.P, Mire, C.E, Lee, A.C.H, Geisbert, J.B, Zhou, J.Z, Agans, K.N, Snead, N.M, Deer, D.J, Barnard, T.R, Fenton, K.A, et al. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature 2015, 521, 362-365. [CrossRef] [PubMed]
-
(2015)
Nature
, vol.521
, pp. 362-365
-
-
Thi, E.P.1
Mire, C.E.2
Lee, A.3
Geisbert, J.B.4
Zhou, J.Z.5
Agans, K.N.6
Snead, N.M.7
Deer, D.J.8
Barnard, T.R.9
Fenton, K.A.10
-
14
-
-
84959351355
-
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
-
Misasi, J, Gilman, M.S.A, Kanekiyo, M, Gui, M, Cagigi, A, Mulangu, S, Corti, D, Ledgerwood, J.E, Lanzavecchia, A, Cunningham, J, et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 2016, 351, 1343-1346. [CrossRef] [PubMed]
-
(2016)
Science
, vol.351
, pp. 1343-1346
-
-
Misasi, J.1
Gilman, M.2
Kanekiyo, M.3
Gui, M.4
Cagigi, A.5
Mulangu, S.6
Corti, D.7
Ledgerwood, J.E.8
Lanzavecchia, A.9
Cunningham, J.10
-
15
-
-
84959359636
-
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
-
Corti, D, Misasi, J, Mulangu, S, Stanley, D.A, Kanekiyo, M, Wollen, S, Ploquin, A, Doria-Rose, N.A, Staupe, R.P, Bailey, M, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 2016, 351, 1339-1342. [CrossRef] [PubMed]
-
(2016)
Science
, vol.351
, pp. 1339-1342
-
-
Corti, D.1
Misasi, J.2
Mulangu, S.3
Stanley, D.A.4
Kanekiyo, M.5
Wollen, S.6
Ploquin, A.7
Doria-Rose, N.A.8
Staupe, R.P.9
Bailey, M.10
-
16
-
-
84960400876
-
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
-
Bornholdt, Z.A, Turner, H.L, Murin, C.D, Li, W, Sok, D, Souders, C.A, Piper, A.E, Goff, A, Shamblin, J.D, Wollen, S.E, et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 2016, 351, 1078-1083. [CrossRef] [PubMed]
-
(2016)
Science
, vol.351
, pp. 1078-1083
-
-
Bornholdt, Z.A.1
Turner, H.L.2
Murin, C.D.3
Li, W.4
Sok, D.5
Souders, C.A.6
Piper, A.E.7
Goff, A.8
Shamblin, J.D.9
Wollen, S.E.10
-
17
-
-
84958078190
-
Discovery of an antibody for pan-ebolavirus therapy
-
Furuyama, W, Marzi, A, Nanbo, A, Haddock, E, Maruyama, J, Miyamoto, H, Igarashi, M, Yoshida, R, Noyori, O, Feldmann, H, et al. Discovery of an antibody for pan-ebolavirus therapy. Sci. Rep. 2016, 6, 20514. [CrossRef] [PubMed]
-
(2016)
Sci. Rep
, vol.6
, pp. 20514
-
-
Furuyama, W.1
Marzi, A.2
Nanbo, A.3
Haddock, E.4
Maruyama, J.5
Miyamoto, H.6
Igarashi, M.7
Yoshida, R.8
Noyori, O.9
Feldmann, H.10
-
18
-
-
84899439262
-
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
-
[CrossRef] [PubMed]
-
Warren, T.K, Wells, J, Panchal, R.G, Stuthman, K.S, Garza, N.L, van Tongeren, S.A, Dong, L, Retterer, C.J, Eaton, B.P, Pegoraro, G, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014. [CrossRef] [PubMed]
-
(2014)
Nature
-
-
Warren, T.K.1
Wells, J.2
Panchal, R.G.3
Stuthman, K.S.4
Garza, N.L.5
Van Tongeren, S.A.6
Dong, L.7
Retterer, C.J.8
Eaton, B.P.9
Pegoraro, G.10
-
19
-
-
84982234143
-
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
-
Warren, T.K, Jordan, R, Lo, M.K, Ray, A.S, Mackman, R.L, Soloveva, V, Siegel, D, Perron, M, Bannister, R, Hui, H.C, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 2016, 531, 381-385. [CrossRef] [PubMed]
-
(2016)
Nature
, vol.531
, pp. 381-385
-
-
Warren, T.K.1
Jordan, R.2
Lo, M.K.3
Ray, A.S.4
Mackman, R.L.5
Soloveva, V.6
Siegel, D.7
Perron, M.8
Bannister, R.9
Hui, H.C.10
-
20
-
-
84880544466
-
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
-
Johansen, L.M, Brannan, J.M, Delos, S.E, Shoemaker, C.J, Stossel, A, Lear, C, Hoffstrom, B.G, Dewald, L.E, Schornberg, K.L, Scully, C, et al. FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection. Sci. Transl. Med. 2013, 5, 190-79. [CrossRef] [PubMed]
-
(2013)
Sci. Transl. Med
, vol.5
, pp. 190-279
-
-
Johansen, L.M.1
Brannan, J.M.2
Delos, S.E.3
Shoemaker, C.J.4
Stossel, A.5
Lear, C.6
Hoffstrom, B.G.7
Dewald, L.E.8
Schornberg, K.L.9
Scully, C.10
-
21
-
-
84930456828
-
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
-
Johansen, L.M, Brannan, J.M, Delos, S.E, Shoemaker, C.J, Stossel, A, Lear, C, Hoffstrom, B.G, Dewald, L.E, Schornberg, K.L, Scully, C, et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 2015, 7, 290-89. [CrossRef] [PubMed]
-
(2015)
Sci. Transl. Med
, vol.7
, pp. 290-389
-
-
Johansen, L.M.1
Brannan, J.M.2
Delos, S.E.3
Shoemaker, C.J.4
Stossel, A.5
Lear, C.6
Hoffstrom, B.G.7
Dewald, L.E.8
Schornberg, K.L.9
Scully, C.10
-
22
-
-
84924964870
-
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
-
Kouznetsova, J, Sun, W, Martínez-Romero, C, Tawa, G, Shinn, P, Chen, C.Z, Schimmer, A, Sanderson, P, McKew, J.C, Zheng, W, et al. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg. Microbes Infect. 2014, 3, e84. [CrossRef] [PubMed]
-
(2014)
Emerg. Microbes Infect
, vol.3
-
-
Kouznetsova, J.1
Sun, W.2
Martínez-Romero, C.3
Tawa, G.4
Shinn, P.5
Chen, C.Z.6
Schimmer, A.7
Sanderson, P.8
McKew, J.C.9
Zheng, W.10
-
23
-
-
84940997614
-
Rong, L. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
-
Cheng, H, Lear-Rooney, C.M, Johansen, L, Varhegyi, E, Chen, Z.W, Olinger, G.G, Rong, L. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. J. Virol. 2015, 89, 9932-9938. [CrossRef] [PubMed]
-
(2015)
J. Virol
, vol.89
, pp. 9932-9938
-
-
Cheng, H.1
Lear-Rooney, C.M.2
Johansen, L.3
Varhegyi, E.4
Chen, Z.W.5
Olinger, G.G.6
-
24
-
-
84875965830
-
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
-
Madrid, P.B, Chopra, S, Manger, I.D, Gilfillan, L, Keepers, T.R, Shurtleff, A.C, Green, C.E, Iyer, L.V, Dilks, H.H, Davey, R.A, et al. A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents. PLoS ONE 2013, 8, e60579. [CrossRef] [PubMed]
-
(2013)
Plos ONE
, vol.8
-
-
Madrid, P.B.1
Chopra, S.2
Manger, I.D.3
Gilfillan, L.4
Keepers, T.R.5
Shurtleff, A.C.6
Green, C.E.7
Iyer, L.V.8
Dilks, H.H.9
Davey, R.A.10
-
25
-
-
0030431525
-
Development, pharmacology and clinical experience with clomiphene citrate
-
Dickey, R.P, Holtkamp, D.E. Development, pharmacology and clinical experience with clomiphene citrate. Hum. Reprod. Update 1996, 2, 483-506. [CrossRef] [PubMed]
-
(1996)
Hum. Reprod. Update
, vol.2
, pp. 483-506
-
-
Dickey, R.P.1
Holtkamp, D.E.2
-
26
-
-
33847159369
-
Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea
-
[CrossRef]
-
Hughes, E, Collins, J, Vandekerckhove, P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst. Rev. 2000, CD000056. [CrossRef]
-
(2000)
Cochrane Database Syst. Rev
-
-
Hughes, E.1
Collins, J.2
Vandekerckhove, P.3
-
27
-
-
78449252145
-
Fertility treatment in women with polycystic ovary syndrome: A decision analysis of different oral ovulation induction agents. Fertil
-
Jungheim, E.S, Odibo, A.O. Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents. Fertil. Steril. 2010, 94, 2659-2664. [CrossRef] [PubMed]
-
(2010)
Steril
, vol.94
, pp. 2659-2664
-
-
Jungheim, E.S.1
Odibo, A.O.2
-
28
-
-
0025989762
-
Possible hypothalamic impotencemale counterpart to hypothalamic amenorrhea?
-
[CrossRef]
-
Guay, A.T, Bansal, S, Hodge, M.B. Possible hypothalamic impotencemale counterpart to hypothalamic amenorrhea? Urology 1991, 38, 317-322. [CrossRef]
-
(1991)
Urology
, vol.38
, pp. 317-322
-
-
Guay, A.T.1
Bansal, S.2
Hodge, M.B.3
-
29
-
-
84874138355
-
Multiple cationic amphiphiles induce a niemann-pick C phenotype and inhibit ebola virus entry and infection
-
[CrossRef]
-
Shoemaker, C.J, Schornberg, K.L, Delos, S.E, Scully, C, Pajouhesh, H, Olinger, G.G, Johansen, L.M, White, J.M. Multiple cationic amphiphiles induce a niemann-pick C phenotype and inhibit ebola virus entry and infection. PLoS ONE 2013, 8, e56265. [CrossRef]
-
(2013)
Plos ONE
, vol.8
-
-
Shoemaker, C.J.1
Schornberg, K.L.2
Delos, S.E.3
Scully, C.4
Pajouhesh, H.5
Olinger, G.G.6
Johansen, L.M.7
White, J.M.8
-
30
-
-
84923050027
-
Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+ Endolysosomes Is a Rate-Defining Step
-
Mingo, R.M, Simmons, J.A, Shoemaker, C.J, Nelson, E.A, Schornberg, K.L, D'Souza, R.S, Casanova, J.E, White, J.M. Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+ Endolysosomes Is a Rate-Defining Step. J. Virol. 2015, 89, 2931-2943. [CrossRef] [PubMed]
-
(2015)
J. Virol
, vol.89
, pp. 2931-2943
-
-
Mingo, R.M.1
Simmons, J.A.2
Shoemaker, C.J.3
Nelson, E.A.4
Schornberg, K.L.5
D'souza, R.S.6
Casanova, J.E.7
White, J.M.8
-
31
-
-
84953897258
-
Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes
-
Simmons, J.A, D’Souza, R.S, Ruas, M, Galione, A, Casanova, J.E, White, J.M. Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes. J. Virol. 2015, 90, 605-610. [CrossRef] [PubMed]
-
(2015)
J. Virol
, vol.90
, pp. 605-610
-
-
Simmons, J.A.1
D’Souza, R.S.2
Ruas, M.3
Galione, A.4
Casanova, J.E.5
White, J.M.6
-
32
-
-
84960157960
-
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway
-
Spence, J.S, Krause, T.B, Mittler, E, Jangra, R.K, Chandran, K. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. MBio 2016, 7, e01857-15. [CrossRef] [PubMed]
-
(2016)
Mbio
, vol.7
, pp. e01857-e01865
-
-
Spence, J.S.1
Krause, T.B.2
Mittler, E.3
Jangra, R.K.4
Chandran, K.5
-
33
-
-
84936947069
-
Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo
-
Herbert, A.S, Davidson, C, Kuehne, A.I, Bakken, R, Braigen, S.Z, Gunn, K.E, Whelan, S.P, Brummelkamp, T.R, Twenhafel, N.A, Chandran, K, et al. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. MBio 2015, 6, e00565-15. [CrossRef] [PubMed]
-
(2015)
Mbio
, vol.6
, pp. e00565-e00615
-
-
Herbert, A.S.1
Davidson, C.2
Kuehne, A.I.3
Bakken, R.4
Braigen, S.Z.5
Gunn, K.E.6
Whelan, S.P.7
Brummelkamp, T.R.8
Twenhafel, N.A.9
Chandran, K.10
-
34
-
-
0019814002
-
Agonistic and antagonistic effects of clomiphene citrate and its isomers
-
Clark, J.H, Guthrie, S.C. Agonistic and antagonistic effects of clomiphene citrate and its isomers. Biol. Reprod. 1981, 25, 667-672. [CrossRef] [PubMed]
-
(1981)
Biol. Reprod
, vol.25
, pp. 667-672
-
-
Clark, J.H.1
Guthrie, S.C.2
-
35
-
-
0033305436
-
Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line
-
Fitzpatrick, S.L, Berrodin, T.J, Jenkins, S.F, Sindoni, D.M, Deecher, D.C, Frail, D.E. Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line. Endocrinology 1999, 140, 3928-3937. [CrossRef] [PubMed]
-
(1999)
Endocrinology
, vol.140
, pp. 3928-3937
-
-
Fitzpatrick, S.L.1
Berrodin, T.J.2
Jenkins, S.F.3
Sindoni, D.M.4
Deecher, D.C.5
Frail, D.E.6
-
36
-
-
72249096282
-
Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency
-
Kaminetsky, J, Hemani, M.L. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency. Expert Opin. Investig. Drugs 2009, 18, 1947-1955. [CrossRef] [PubMed]
-
(2009)
Expert Opin. Investig. Drugs
, vol.18
, pp. 1947-1955
-
-
Kaminetsky, J.1
Hemani, M.L.2
-
37
-
-
0022449090
-
Single-dose pharmacokinetics of clomiphene citrate in normal volunteers
-
[CrossRef]
-
Mikkelson, T.J, Kroboth, P.D, Cameron, W.J, Dittert, L.W, Chungi, V, Manberg, P.J. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil. Steril. 1986, 46, 392-396. [CrossRef]
-
(1986)
Fertil. Steril
, vol.46
, pp. 392-396
-
-
Mikkelson, T.J.1
Kroboth, P.D.2
Cameron, W.J.3
Dittert, L.W.4
Chungi, V.5
Manberg, P.J.6
-
38
-
-
84856951058
-
Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites
-
Mürdter, T.E, Kerb, R, Turpeinen, M, Schroth, W, Ganchev, B, Böhmer, G.M, Igel, S, Schaeffeler, E, Zanger, U, Brauch, H, et al. Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites. Hum. Mol. Genet. 2012, 21, 1145-1154. [CrossRef] [PubMed]
-
(2012)
Hum. Mol. Genet
, vol.21
, pp. 1145-1154
-
-
Mürdter, T.E.1
Kerb, R.2
Turpeinen, M.3
Schroth, W.4
Ganchev, B.5
Böhmer, G.M.6
Igel, S.7
Schaeffeler, E.8
Zanger, U.9
Brauch, H.10
-
39
-
-
84981545974
-
-
Manuscript preparation
-
Wiehle, R.D, Fontenot, G.K, Hsu, K, Podolski, J. The Isomers of Clomiphene Citrate Have Dissimilar Dispositions Once Ingested: Results of a Mouse ADE Study. Manuscript preparation. 2016.
-
(2016)
The Isomers of Clomiphene Citrate have Dissimilar Dispositions Once Ingested: Results of a Mouse ADE Study
-
-
Wiehle, R.D.1
Fontenot, G.K.2
Hsu, K.3
Podolski, J.4
-
40
-
-
84954388577
-
Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice
-
Fontenot, G.K, Wiehle, R.D, Podolski, J.S. Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice. BJU Int. 2016, 117, 344-350. [CrossRef] [PubMed]
-
(2016)
BJU Int
, vol.117
, pp. 344-350
-
-
Fontenot, G.K.1
Wiehle, R.D.2
Podolski, J.S.3
-
41
-
-
84887284539
-
Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: A pharmacodynamic and pharmacokinetic study
-
Wiehle, R, Cunningham, G.R, Pitteloud, N, Wike, J, Hsu, K, Fontenot, G.K, Rosner, M, Dwyer, A, Podolski, J. Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study. BJU Int. 2013, 112, 1188-1200. [CrossRef] [PubMed]
-
(2013)
BJU Int
, vol.112
, pp. 1188-1200
-
-
Wiehle, R.1
Cunningham, G.R.2
Pitteloud, N.3
Wike, J.4
Hsu, K.5
Fontenot, G.K.6
Rosner, M.7
Dwyer, A.8
Podolski, J.9
-
42
-
-
84906342319
-
Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
-
Watt, A, Moukambi, F, Banadyga, L, Groseth, A, Callison, J, Herwig, A, Ebihara, H, Feldmann, H, Hoenen, T. A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity. J. Virol. 2014, 88, 10511-10524. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 10511-10524
-
-
Watt, A.1
Moukambi, F.2
Banadyga, L.3
Groseth, A.4
Callison, J.5
Herwig, A.6
Ebihara, H.7
Feldmann, H.8
Hoenen, T.A.9
-
43
-
-
84908283335
-
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 ConditionsWith Virus-like Particles Containing Tetracistronic Minigenomes
-
[CrossRef] [PubMed]
-
Hoenen, T, Watt, A, Mora, A, Feldmann, H. Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 ConditionsWith Virus-like Particles Containing Tetracistronic Minigenomes. J. Vis. Exp. 2014. [CrossRef] [PubMed]
-
(2014)
J. Vis. Exp
-
-
Hoenen, T.1
Watt, A.2
Mora, A.3
Feldmann, H.4
-
44
-
-
84872684808
-
-
(accessed on 5 July 2016)
-
GraphPad Software QuickCalcs. Available online: http://www.graphpad.com/quickcalcs/Ecanything1/ (accessed on 5 July 2016).
-
Graphpad Software Quickcalcs
-
-
-
45
-
-
58849127737
-
Single-dose pharmacokinetic study of clomiphene citrate isomers in anovular patients with polycystic ovary disease
-
Ghobadi, C, Mirhosseini, N, Shiran, M.R, Moghadamnia, A, Lennard, M.S, Ledger, W.L, Rostami-Hodjegan, A. Single-dose pharmacokinetic study of clomiphene citrate isomers in anovular patients with polycystic ovary disease. J. Clin. Pharmacol. 2009, 49, 147-154. [CrossRef] [PubMed]
-
(2009)
J. Clin. Pharmacol
, vol.49
, pp. 147-154
-
-
Ghobadi, C.1
Mirhosseini, N.2
Shiran, M.R.3
Moghadamnia, A.4
Lennard, M.S.5
Ledger, W.L.6
Rostami-Hodjegan, A.7
-
46
-
-
40449086665
-
Dose translation from animal to human studies revisited
-
Reagan-Shaw, S, Nihal, M, Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661. [CrossRef] [PubMed]
-
(2008)
FASEB J
, vol.22
, pp. 659-661
-
-
Reagan-Shaw, S.1
Nihal, M.2
Ahmad, N.3
-
47
-
-
2342523311
-
Monitoring plasma concentrations to individualize treatment with clomiphene citrate
-
Rostami-Hodjegan, A, Lennard, M.S, Tucker, G.T, Ledger, W.L. Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertil. Steril. 2004, 81, 1187-1193. [CrossRef] [PubMed]
-
(2004)
Fertil. Steril
, vol.81
, pp. 1187-1193
-
-
Rostami-Hodjegan, A.1
Lennard, M.S.2
Tucker, G.T.3
Ledger, W.L.4
-
48
-
-
0033021006
-
Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women
-
[CrossRef]
-
Young, S.L, Opsahl, M.S, Fritz, M.A. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil. Steril. 1999, 71, 639-644. [CrossRef]
-
(1999)
Fertil. Steril
, vol.71
, pp. 639-644
-
-
Young, S.L.1
Opsahl, M.S.2
Fritz, M.A.3
-
49
-
-
0024381127
-
Pharmacokinetics of intravenous clomiphene isomers
-
Szutu, M, Morgan, D.J, McLeish, M, Phillipou, G, Blackman, G.L, Cox, L.W, Dollman, W. Pharmacokinetics of intravenous clomiphene isomers. Br. J. Clin. Pharmacol. 1989, 27, 639-640. [CrossRef] [PubMed]
-
(1989)
Br. J. Clin. Pharmacol
, vol.27
, pp. 639-640
-
-
Szutu, M.1
Morgan, D.J.2
McLeish, M.3
Phillipou, G.4
Blackman, G.L.5
Cox, L.W.6
Dollman, W.7
|